Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$111.86
+1.4%
$111.60
$88.96
$136.72
$2.06B0.81166,252 shs91,160 shs
Amedisys, Inc. stock logo
AMED
Amedisys
$96.14
+0.2%
$95.61
$82.15
$98.95
$3.15B0.94420,526 shs355,257 shs
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
$10.80
$10.80
$10.05
$11.68
$209.10M0.01122,781 shs5,636 shs
Chemed Corporation stock logo
CHE
Chemed
$472.61
+0.3%
$555.54
$469.80
$623.61
$6.92B0.5110,862 shs90,753 shs
LHC Group, Inc. stock logo
LHCG
LHC Group
$169.81
$166.14
$115.32
$169.84
$5.27B0.43576,665 shsN/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.00%-2.83%-0.27%+11.51%-4.70%
Amedisys, Inc. stock logo
AMED
Amedisys
0.00%-1.82%+2.41%+4.63%-1.19%
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
0.00%0.00%0.00%-0.05%-0.05%
Chemed Corporation stock logo
CHE
Chemed
0.00%-15.41%-15.57%-20.99%-12.39%
LHC Group, Inc. stock logo
LHCG
LHC Group
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.9794 of 5 stars
3.65.00.05.02.62.53.1
Amedisys, Inc. stock logo
AMED
Amedisys
2.7047 of 5 stars
1.11.00.05.01.81.71.3
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
4.9664 of 5 stars
3.53.03.34.92.42.52.5
LHC Group, Inc. stock logo
LHCG
LHC Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
3.25
Buy$142.5727.46% Upside
Amedisys, Inc. stock logo
AMED
Amedisys
2.25
Hold$100.754.80% Upside
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
0.00
N/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
3.00
Buy$645.0036.48% Upside
LHC Group, Inc. stock logo
LHCG
LHC Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CHE, AMED, LHCG, BIOS, and ADUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Chemed Corporation stock logo
CHE
Chemed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$674.00 ➝ $640.00
6/30/2025
Chemed Corporation stock logo
CHE
Chemed
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$708.00 ➝ $650.00
6/20/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00
6/10/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$133.00
5/8/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.00
4/28/2025
Chemed Corporation stock logo
CHE
Chemed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.00
4/22/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
4/16/2025
Amedisys, Inc. stock logo
AMED
Amedisys
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
4/10/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.21B1.70$5.39 per share20.75$53.52 per share2.09
Amedisys, Inc. stock logo
AMED
Amedisys
$2.35B1.34$6.23 per share15.42$36.03 per share2.67
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$2.43B2.84$25.69 per share18.40$74.35 per share6.36
LHC Group, Inc. stock logo
LHCG
LHC Group
$2.22B2.37$7.51 per share22.60$52.17 per share3.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$73.60M$4.4325.2520.871.586.52%9.23%6.96%8/4/2025 (Estimated)
Amedisys, Inc. stock logo
AMED
Amedisys
$43.23M$2.7135.4819.861.313.79%12.52%7.01%7/23/2025 (Estimated)
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$302M$20.5323.0220.282.2812.40%27.58%18.96%7/29/2025 (Estimated)
LHC Group, Inc. stock logo
LHCG
LHC Group
$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/A

Latest CHE, AMED, LHCG, BIOS, and ADUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Amedisys, Inc. stock logo
AMED
Amedisys
$1.39N/AN/AN/A$614.61 millionN/A
7/23/2025Q2 2025
Chemed Corporation stock logo
CHE
Chemed
$6.02N/AN/AN/A$650.60 millionN/A
5/5/2025Q1 2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.33$1.42+$0.09$1.16$341.66 million$337.71 million
4/23/2025Q1 2025
Amedisys, Inc. stock logo
AMED
Amedisys
$1.13$1.25+$0.12$1.84$597.43 million$594.78 million
4/23/2025Q1 2025
Chemed Corporation stock logo
CHE
Chemed
$5.59$5.63+$0.04$4.86$641.78 million$646.94 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$2.000.42%N/A9.74%16 Years
LHC Group, Inc. stock logo
LHCG
LHC Group
N/AN/AN/AN/AN/A

Latest CHE, AMED, LHCG, BIOS, and ADUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2025
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.500.3%5/29/20255/29/20256/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.20
1.74
1.74
Amedisys, Inc. stock logo
AMED
Amedisys
0.27
1.29
1.29
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
N/A
1.73
1.70
LHC Group, Inc. stock logo
LHCG
LHC Group
0.44
1.45
1.45

Institutional Ownership

CompanyInstitutional Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
95.35%
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
66.19%
Chemed Corporation stock logo
CHE
Chemed
95.85%
LHC Group, Inc. stock logo
LHCG
LHC Group
83.47%

Insider Ownership

CompanyInsider Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.60%
Amedisys, Inc. stock logo
AMED
Amedisys
2.10%
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
22.60%
Chemed Corporation stock logo
CHE
Chemed
3.29%
LHC Group, Inc. stock logo
LHCG
LHC Group
4.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
49,70318.40 million17.55 millionOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
19,00032.82 million32.13 millionOptionable
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/A19.37 million14.99 millionNot Optionable
Chemed Corporation stock logo
CHE
Chemed
15,69514.63 million14.15 millionOptionable
LHC Group, Inc. stock logo
LHCG
LHC Group
30,00031.03 million29.54 millionOptionable

Recent News About These Companies

Optum, LHC Group Put Pedal Down On Home-Based Care Efforts
3 Stocks Raising Dividends 4X Higher Than Inflation
Next-generation triggers for HL-LHC and beyond
Life Healthcare Group Holdings Ltd.
LHC Group Stock Hits New 52-Week Low (LHCG)

Media Sentiment Over Time

Top Headlines

View All Headlines
Addus HomeCare stock logo

Addus HomeCare NASDAQ:ADUS

$111.86 +1.49 (+1.35%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$111.86 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Amedisys stock logo

Amedisys NASDAQ:AMED

$96.14 +0.18 (+0.19%)
Closing price 07/3/2025 01:10 PM Eastern
Extended Trading
$96.14 0.00 (0.00%)
As of 07/3/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

BioPlus Acquisition stock logo

BioPlus Acquisition NASDAQ:BIOS

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Chemed stock logo

Chemed NYSE:CHE

$472.60 +1.37 (+0.29%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$472.60 0.00 (0.00%)
As of 07/3/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

LHC Group stock logo

LHC Group NASDAQ:LHCG

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical perso